Twenty early-career cancer researchers from around the world were selected for the 2026 AACR Global Scholar-in-Training Award (GSITA) programs.
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
Today, September 24, 2018, is World Cancer Research Day. The American Association for Cancer Research (AACR) is proud to...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
Today, the American Association for Cancer Research (AACR) released its eighth annual Cancer Progress Report. The report highlights how...